Global Heparin Supply, Demand and Key Producers, 2023-2029
Page: 145
Published Date: 18 Oct 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Heparin market size is expected to reach $ 3877.2 million by 2029, rising at a market growth of 7.1% CAGR during the forecast period (2023-2029).
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
This report studies the global Heparin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Heparin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Heparin total production and demand, 2018-2029, (B Units)
Global Heparin total production value, 2018-2029, (USD Million)
Global Heparin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (B Units)
Global Heparin consumption by region & country, CAGR, 2018-2029 & (B Units)
U.S. VS China: Heparin domestic production, consumption, key domestic manufacturers and share
Global Heparin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (B Units)
Global Heparin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (B Units)
Global Heparin production by Application production, value, CAGR, 2018-2029, (USD Million) & (B Units).
This reports profiles key players in the global Heparin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical and Opocrin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (B Units) and average price (US$/B Units) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Heparin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Heparin Market, Segmentation by Type
Heparin Sodium
Heparin Calcium
Global Heparin Market, Segmentation by Application
UFH
LMWH
Companies Profiled:
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Key Questions Answered
1. How big is the global Heparin market?
2. What is the demand of the global Heparin market?
3. What is the year over year growth of the global Heparin market?
4. What is the production and production value of the global Heparin market?
5. Who are the key producers in the global Heparin market?
Table of Contents
1 Supply Summary
1.1 Heparin Introduction
1.2 World Heparin Supply & Forecast
1.2.1 World Heparin Production Value (2018 & 2022 & 2029)
1.2.2 World Heparin Production (2018-2029)
1.2.3 World Heparin Pricing Trends (2018-2029)
1.3 World Heparin Production by Region (Based on Production Site)
1.3.1 World Heparin Production Value by Region (2018-2029)
1.3.2 World Heparin Production by Region (2018-2029)
1.3.3 World Heparin Average Price by Region (2018-2029)
1.3.4 North America Heparin Production (2018-2029)
1.3.5 Europe Heparin Production (2018-2029)
1.3.6 China Heparin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Heparin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Heparin Major Market Trends
2 Demand Summary
2.1 World Heparin Demand (2018-2029)
2.2 World Heparin Consumption by Region
2.2.1 World Heparin Consumption by Region (2018-2023)
2.2.2 World Heparin Consumption Forecast by Region (2024-2029)
2.3 United States Heparin Consumption (2018-2029)
2.4 China Heparin Consumption (2018-2029)
2.5 Europe Heparin Consumption (2018-2029)
2.6 Japan Heparin Consumption (2018-2029)
2.7 South Korea Heparin Consumption (2018-2029)
2.8 ASEAN Heparin Consumption (2018-2029)
2.9 India Heparin Consumption (2018-2029)
3 World Heparin Manufacturers Competitive Analysis
3.1 World Heparin Production Value by Manufacturer (2018-2023)
3.2 World Heparin Production by Manufacturer (2018-2023)
3.3 World Heparin Average Price by Manufacturer (2018-2023)
3.4 Heparin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Heparin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Heparin in 2022
3.5.3 Global Concentration Ratios (CR8) for Heparin in 2022
3.6 Heparin Market: Overall Company Footprint Analysis
3.6.1 Heparin Market: Region Footprint
3.6.2 Heparin Market: Company Product Type Footprint
3.6.3 Heparin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Heparin Production Value Comparison
4.1.1 United States VS China: Heparin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Heparin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Heparin Production Comparison
4.2.1 United States VS China: Heparin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Heparin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Heparin Consumption Comparison
4.3.1 United States VS China: Heparin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Heparin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Heparin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Heparin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Heparin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Heparin Production (2018-2023)
4.5 China Based Heparin Manufacturers and Market Share
4.5.1 China Based Heparin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Heparin Production Value (2018-2023)
4.5.3 China Based Manufacturers Heparin Production (2018-2023)
4.6 Rest of World Based Heparin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Heparin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Heparin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Heparin Production (2018-2023)
5 Market Analysis by Type
5.1 World Heparin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Heparin Sodium
5.2.2 Heparin Calcium
5.3 Market Segment by Type
5.3.1 World Heparin Production by Type (2018-2029)
5.3.2 World Heparin Production Value by Type (2018-2029)
5.3.3 World Heparin Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Heparin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 UFH
6.2.2 LMWH
6.3 Market Segment by Application
6.3.1 World Heparin Production by Application (2018-2029)
6.3.2 World Heparin Production Value by Application (2018-2029)
6.3.3 World Heparin Average Price by Application (2018-2029)
7 Company Profiles
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Details
7.1.2 Shenzhen Hepalink Pharmaceutical Major Business
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Product and Services
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
7.1.6 Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Details
7.2.2 Yantai Dongcheng Pharmaceutical Major Business
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Product and Services
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
7.2.6 Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Heparin Product and Services
7.3.4 Pfizer Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Bioibérica
7.4.1 Bioibérica Details
7.4.2 Bioibérica Major Business
7.4.3 Bioibérica Heparin Product and Services
7.4.4 Bioibérica Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bioibérica Recent Developments/Updates
7.4.6 Bioibérica Competitive Strengths & Weaknesses
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Details
7.5.2 Changzhou Qianhong Biopharma Major Business
7.5.3 Changzhou Qianhong Biopharma Heparin Product and Services
7.5.4 Changzhou Qianhong Biopharma Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
7.5.6 Changzhou Qianhong Biopharma Competitive Strengths & Weaknesses
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Details
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
7.6.6 Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Details
7.7.2 Hebei Changshan Biochemical Pharmaceutical Major Business
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
7.7.6 Hebei Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Details
7.8.2 Qingdao Jiulong Biopharmaceutical Major Business
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Product and Services
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
7.8.6 Qingdao Jiulong Biopharmaceutical Competitive Strengths & Weaknesses
7.9 Opocrin
7.9.1 Opocrin Details
7.9.2 Opocrin Major Business
7.9.3 Opocrin Heparin Product and Services
7.9.4 Opocrin Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Opocrin Recent Developments/Updates
7.9.6 Opocrin Competitive Strengths & Weaknesses
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Details
7.10.2 Dongying Tiandong Pharmaceutical Major Business
7.10.3 Dongying Tiandong Pharmaceutical Heparin Product and Services
7.10.4 Dongying Tiandong Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
7.10.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
7.11 Aspen Oss
7.11.1 Aspen Oss Details
7.11.2 Aspen Oss Major Business
7.11.3 Aspen Oss Heparin Product and Services
7.11.4 Aspen Oss Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Aspen Oss Recent Developments/Updates
7.11.6 Aspen Oss Competitive Strengths & Weaknesses
7.12 Yino Pharma
7.12.1 Yino Pharma Details
7.12.2 Yino Pharma Major Business
7.12.3 Yino Pharma Heparin Product and Services
7.12.4 Yino Pharma Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Yino Pharma Recent Developments/Updates
7.12.6 Yino Pharma Competitive Strengths & Weaknesses
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Details
7.13.2 Nanjing Xinbai Pharmaceutical Major Business
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Product and Services
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
7.13.6 Nanjing Xinbai Pharmaceutical Competitive Strengths & Weaknesses
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Details
7.14.2 Hubei Enoray Biopharmaceutical Major Business
7.14.3 Hubei Enoray Biopharmaceutical Heparin Product and Services
7.14.4 Hubei Enoray Biopharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
7.14.6 Hubei Enoray Biopharmaceutical Competitive Strengths & Weaknesses
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Details
7.15.2 Cisen Pharmaceutical Major Business
7.15.3 Cisen Pharmaceutical Heparin Product and Services
7.15.4 Cisen Pharmaceutical Heparin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Cisen Pharmaceutical Recent Developments/Updates
7.15.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Heparin Industry Chain
8.2 Heparin Upstream Analysis
8.2.1 Heparin Core Raw Materials
8.2.2 Main Manufacturers of Heparin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Heparin Production Mode
8.6 Heparin Procurement Model
8.7 Heparin Industry Sales Model and Sales Channels
8.7.1 Heparin Sales Model
8.7.2 Heparin Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Heparin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Heparin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Heparin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Heparin Production Value Market Share by Region (2018-2023)
Table 5. World Heparin Production Value Market Share by Region (2024-2029)
Table 6. World Heparin Production by Region (2018-2023) & (B Units)
Table 7. World Heparin Production by Region (2024-2029) & (B Units)
Table 8. World Heparin Production Market Share by Region (2018-2023)
Table 9. World Heparin Production Market Share by Region (2024-2029)
Table 10. World Heparin Average Price by Region (2018-2023) & (US$/B Units)
Table 11. World Heparin Average Price by Region (2024-2029) & (US$/B Units)
Table 12. Heparin Major Market Trends
Table 13. World Heparin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (B Units)
Table 14. World Heparin Consumption by Region (2018-2023) & (B Units)
Table 15. World Heparin Consumption Forecast by Region (2024-2029) & (B Units)
Table 16. World Heparin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Heparin Producers in 2022
Table 18. World Heparin Production by Manufacturer (2018-2023) & (B Units)
Table 19. Production Market Share of Key Heparin Producers in 2022
Table 20. World Heparin Average Price by Manufacturer (2018-2023) & (US$/B Units)
Table 21. Global Heparin Company Evaluation Quadrant
Table 22. World Heparin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Heparin Production Site of Key Manufacturer
Table 24. Heparin Market: Company Product Type Footprint
Table 25. Heparin Market: Company Product Application Footprint
Table 26. Heparin Competitive Factors
Table 27. Heparin New Entrant and Capacity Expansion Plans
Table 28. Heparin Mergers & Acquisitions Activity
Table 29. United States VS China Heparin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Heparin Production Comparison, (2018 & 2022 & 2029) & (B Units)
Table 31. United States VS China Heparin Consumption Comparison, (2018 & 2022 & 2029) & (B Units)
Table 32. United States Based Heparin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Heparin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Heparin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Heparin Production (2018-2023) & (B Units)
Table 36. United States Based Manufacturers Heparin Production Market Share (2018-2023)
Table 37. China Based Heparin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Heparin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Heparin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Heparin Production (2018-2023) & (B Units)
Table 41. China Based Manufacturers Heparin Production Market Share (2018-2023)
Table 42. Rest of World Based Heparin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Heparin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Heparin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Heparin Production (2018-2023) & (B Units)
Table 46. Rest of World Based Manufacturers Heparin Production Market Share (2018-2023)
Table 47. World Heparin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Heparin Production by Type (2018-2023) & (B Units)
Table 49. World Heparin Production by Type (2024-2029) & (B Units)
Table 50. World Heparin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Heparin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Heparin Average Price by Type (2018-2023) & (US$/B Units)
Table 53. World Heparin Average Price by Type (2024-2029) & (US$/B Units)
Table 54. World Heparin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Heparin Production by Application (2018-2023) & (B Units)
Table 56. World Heparin Production by Application (2024-2029) & (B Units)
Table 57. World Heparin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Heparin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Heparin Average Price by Application (2018-2023) & (US$/B Units)
Table 60. World Heparin Average Price by Application (2024-2029) & (US$/B Units)
Table 61. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Shenzhen Hepalink Pharmaceutical Major Business
Table 63. Shenzhen Hepalink Pharmaceutical Heparin Product and Services
Table 64. Shenzhen Hepalink Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 66. Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Yantai Dongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Yantai Dongcheng Pharmaceutical Major Business
Table 69. Yantai Dongcheng Pharmaceutical Heparin Product and Services
Table 70. Yantai Dongcheng Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 72. Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Heparin Product and Services
Table 76. Pfizer Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Bioibérica Basic Information, Manufacturing Base and Competitors
Table 80. Bioibérica Major Business
Table 81. Bioibérica Heparin Product and Services
Table 82. Bioibérica Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bioibérica Recent Developments/Updates
Table 84. Bioibérica Competitive Strengths & Weaknesses
Table 85. Changzhou Qianhong Biopharma Basic Information, Manufacturing Base and Competitors
Table 86. Changzhou Qianhong Biopharma Major Business
Table 87. Changzhou Qianhong Biopharma Heparin Product and Services
Table 88. Changzhou Qianhong Biopharma Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 90. Changzhou Qianhong Biopharma Competitive Strengths & Weaknesses
Table 91. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Nanjing King-friend Biochemical Pharmaceutical Major Business
Table 93. Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
Table 94. Nanjing King-friend Biochemical Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 96. Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Hebei Changshan Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Hebei Changshan Biochemical Pharmaceutical Major Business
Table 99. Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
Table 100. Hebei Changshan Biochemical Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 102. Hebei Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Qingdao Jiulong Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Qingdao Jiulong Biopharmaceutical Major Business
Table 105. Qingdao Jiulong Biopharmaceutical Heparin Product and Services
Table 106. Qingdao Jiulong Biopharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 108. Qingdao Jiulong Biopharmaceutical Competitive Strengths & Weaknesses
Table 109. Opocrin Basic Information, Manufacturing Base and Competitors
Table 110. Opocrin Major Business
Table 111. Opocrin Heparin Product and Services
Table 112. Opocrin Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Opocrin Recent Developments/Updates
Table 114. Opocrin Competitive Strengths & Weaknesses
Table 115. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Dongying Tiandong Pharmaceutical Major Business
Table 117. Dongying Tiandong Pharmaceutical Heparin Product and Services
Table 118. Dongying Tiandong Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 120. Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Aspen Oss Basic Information, Manufacturing Base and Competitors
Table 122. Aspen Oss Major Business
Table 123. Aspen Oss Heparin Product and Services
Table 124. Aspen Oss Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Aspen Oss Recent Developments/Updates
Table 126. Aspen Oss Competitive Strengths & Weaknesses
Table 127. Yino Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Yino Pharma Major Business
Table 129. Yino Pharma Heparin Product and Services
Table 130. Yino Pharma Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Yino Pharma Recent Developments/Updates
Table 132. Yino Pharma Competitive Strengths & Weaknesses
Table 133. Nanjing Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Nanjing Xinbai Pharmaceutical Major Business
Table 135. Nanjing Xinbai Pharmaceutical Heparin Product and Services
Table 136. Nanjing Xinbai Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
Table 138. Nanjing Xinbai Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Hubei Enoray Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Hubei Enoray Biopharmaceutical Major Business
Table 141. Hubei Enoray Biopharmaceutical Heparin Product and Services
Table 142. Hubei Enoray Biopharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 144. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Cisen Pharmaceutical Major Business
Table 146. Cisen Pharmaceutical Heparin Product and Services
Table 147. Cisen Pharmaceutical Heparin Production (B Units), Price (US$/B Units), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Heparin Upstream (Raw Materials)
Table 149. Heparin Typical Customers
Table 150. Heparin Typical Distributors
List of Figure
Figure 1. Heparin Picture
Figure 2. World Heparin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Heparin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Heparin Production (2018-2029) & (B Units)
Figure 5. World Heparin Average Price (2018-2029) & (US$/B Units)
Figure 6. World Heparin Production Value Market Share by Region (2018-2029)
Figure 7. World Heparin Production Market Share by Region (2018-2029)
Figure 8. North America Heparin Production (2018-2029) & (B Units)
Figure 9. Europe Heparin Production (2018-2029) & (B Units)
Figure 10. China Heparin Production (2018-2029) & (B Units)
Figure 11. Heparin Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Heparin Consumption (2018-2029) & (B Units)
Figure 14. World Heparin Consumption Market Share by Region (2018-2029)
Figure 15. United States Heparin Consumption (2018-2029) & (B Units)
Figure 16. China Heparin Consumption (2018-2029) & (B Units)
Figure 17. Europe Heparin Consumption (2018-2029) & (B Units)
Figure 18. Japan Heparin Consumption (2018-2029) & (B Units)
Figure 19. South Korea Heparin Consumption (2018-2029) & (B Units)
Figure 20. ASEAN Heparin Consumption (2018-2029) & (B Units)
Figure 21. India Heparin Consumption (2018-2029) & (B Units)
Figure 22. Producer Shipments of Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 23. Global Four-firm Concentration Ratios (CR4) for Heparin Markets in 2022
Figure 24. Global Four-firm Concentration Ratios (CR8) for Heparin Markets in 2022
Figure 25. United States VS China: Heparin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 26. United States VS China: Heparin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Heparin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States Based Manufacturers Heparin Production Market Share 2022
Figure 29. China Based Manufacturers Heparin Production Market Share 2022
Figure 30. Rest of World Based Manufacturers Heparin Production Market Share 2022
Figure 31. World Heparin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 32. World Heparin Production Value Market Share by Type in 2022
Figure 33. Heparin Sodium
Figure 34. Heparin Calcium
Figure 35. World Heparin Production Market Share by Type (2018-2029)
Figure 36. World Heparin Production Value Market Share by Type (2018-2029)
Figure 37. World Heparin Average Price by Type (2018-2029) & (US$/B Units)
Figure 38. World Heparin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 39. World Heparin Production Value Market Share by Application in 2022
Figure 40. UFH
Figure 41. LMWH
Figure 42. World Heparin Production Market Share by Application (2018-2029)
Figure 43. World Heparin Production Value Market Share by Application (2018-2029)
Figure 44. World Heparin Average Price by Application (2018-2029) & (US$/B Units)
Figure 45. Heparin Industry Chain
Figure 46. Heparin Procurement Model
Figure 47. Heparin Sales Model
Figure 48. Heparin Sales Channels, Direct Sales, and Distribution
Figure 49. Methodology
Figure 50. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Shenzhen Hepalink Pharmaceutical Yantai Dongcheng Pharmaceutical Pfizer Bioibérica Changzhou Qianhong Biopharma Nanjing King-friend Biochemical Pharmaceutical Hebei Changshan Biochemical Pharmaceutical Qingdao Jiulong Biopharmaceutical Opocrin Dongying Tiandong Pharmaceutical Aspen Oss Yino Pharma Nanjing Xinbai Pharmaceutical Hubei Enoray Biopharmaceutical Cisen Pharmaceutical
Related Reports
Product Tags
Heparin (Heparin Sodium and Heparin Calcium)
Heparin Sodium API and Heparin Calcium API
Heparin-induced Thrombocytopenia Treatment
Low Molecular Weight Heparin Sodium
Heparin Sodium Active Pharmaceutical Ingredient
Low Molecular Heparin Preparation
Ultra-low Molecular Weight Heparin (ULMWH)
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>